SEC Form 4 · accession 0001437749-17-002572
Proto Labs Inc · PRLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Victoria M Holt
Officer — President and CEO · Director
Period of report
Feb 13, 2017
Accepted (ET)
Feb 15, 2017 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001443669
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2017 | A | 12,855 | $58.35 | A | 44,018 | D | |
| Common StockF2 | Feb 15, 2017 | S | 2,025 | $56.8026 | D | 41,993 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $58.35 | Feb 13, 2017 | A | 9,070 | A | — | Feb 13, 2027 | Common Stock | 9,070 | 9,070 | D |
Explanation of responses
- F1The restricted stock units vest as to 20% of the shares in five annual installments beginning on February 13, 2018.
- F2Reflects the weighted average price of 2,025 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 15, 2017 with sale prices ranging from $56.75 to $56.95 per share. The reporting, person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F3The option vests as to 20% of the shares in five annual installments beginning on February 13, 2018.